China New City Group Statistics

Total Valuation

FRA:C7B has a market cap or net worth of EUR 142.53 million. The enterprise value is 672.85 million.

Market Cap	142.53M
Enterprise Value	672.85M

Important Dates

The last earnings date was Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.84B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.70%
Owned by Institutions (%)	n/a
Float	485.16M

Valuation Ratios

The trailing PE ratio is 13.24.

PE Ratio	13.24
Forward PE	n/a
PS Ratio	0.77
PB Ratio	0.23
P/TBV Ratio	0.23
P/FCF Ratio	144.70
P/OCF Ratio	20.17
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 683.09.

EV / Earnings	62.48
EV / Sales	3.59
EV / EBITDA	12.77
EV / EBIT	17.28
EV / FCF	683.09

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.86.

Current Ratio	1.67
Quick Ratio	0.09
Debt / Equity	0.86
Debt / EBITDA	10.31
Debt / FCF	545.24
Interest Coverage	1.93

Financial Efficiency

Return on equity (ROE) is 1.89% and return on invested capital (ROIC) is 2.21%.

Return on Equity (ROE)	1.89%
Return on Assets (ROA)	1.52%
Return on Invested Capital (ROIC)	2.21%
Return on Capital Employed (ROCE)	3.23%
Revenue Per Employee	160,446
Profits Per Employee	9,389
Employee Count	1,232
Asset Turnover	0.12
Inventory Turnover	0.24

Taxes

In the past 12 months, FRA:C7B has paid 14.44 million in taxes.

Income Tax	14.44M
Effective Tax Rate	55.14%

Stock Price Statistics

The stock price has decreased by -22.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.64%
50-Day Moving Average	0.07
200-Day Moving Average	0.07
Relative Strength Index (RSI)	43.79
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:C7B had revenue of EUR 184.03 million and earned 10.77 million in profits. Earnings per share was 0.01.

Revenue	184.03M
Gross Profit	66.17M
Operating Income	38.58M
Pretax Income	26.18M
Net Income	10.77M
EBITDA	50.39M
EBIT	38.58M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 24.80 million in cash and 537.06 million in debt, giving a net cash position of -512.26 million.

Cash & Cash Equivalents	24.80M
Total Debt	537.06M
Net Cash	-512.26M
Net Cash Per Share	n/a
Equity (Book Value)	625.51M
Book Value Per Share	0.31
Working Capital	258.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.07 million and capital expenditures -6.08 million, giving a free cash flow of 985,005.

Operating Cash Flow	7.07M
Capital Expenditures	-6.08M
Free Cash Flow	985,005
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 35.96%, with operating and profit margins of 20.96% and 5.85%.

Gross Margin	35.96%
Operating Margin	20.96%
Pretax Margin	14.23%
Profit Margin	5.85%
EBITDA Margin	27.38%
EBIT Margin	20.96%
FCF Margin	0.54%

Dividends & Yields

FRA:C7B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.56%
FCF Yield	0.69%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:C7B has an Altman Z-Score of 0.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.79
Piotroski F-Score	4